HS
HighVista Strategies Portfolio holdings
AUM
$272M
This Quarter Return
+16.91%
1 Year Return
+24.34%
3 Year Return
+176.43%
5 Year Return
+271.23%
10 Year Return
+682.63%
AUM
$276M
AUM Growth
+$276M
(+28%)
Cap. Flow
+$45.5M
Cap. Flow
% of AUM
16.5%
Top 10 Holdings %
Top 10 Hldgs %
29.49%
Holding
157
New
25
Increased
65
Reduced
12
Closed
31
Top Buys
| 1 |
Spyre Therapeutics
SYRE
|
$12.4M |
| 2 |
HES
Hess
HES
|
$4.17M |
| 3 |
SOVO
Sovos Brands, Inc. Common Stock
SOVO
|
$4.07M |
| 4 |
SP
SP Plus Corporation
SP
|
$4.04M |
| 5 |
UiPath
PATH
|
$3.07M |
Top Sells
Sector Composition
| 1 | Healthcare | 45.71% |
| 2 | Technology | 11.75% |
| 3 | Consumer Discretionary | 6.51% |
| 4 | Industrials | 5.31% |
| 5 | Consumer Staples | 4.66% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
26
UiPath
PATH
$5.82B
| $3.07M | 1.11% |
+123,675
| New | +$3.07M |
|
27
Structure Therapeutics
GPCR
$1.14B
| $3.05M | 1.11% |
74,832
| – | – |
|
|
TXNM
28
TXNM Energy, Inc.
TXNM
$5.97B
| $2.91M | 1.06% |
69,909
| – | – |
|
29
Ionis Pharmaceuticals
IONS
$9.64B
| $2.9M | 1.05% |
57,348
+8,828
| +18% | +$447K |
|
|
AMAM
30
DELISTED
Ambrx Biopharma, Inc. Common Stock
AMAM
| $2.89M | 1.05% |
203,122
+9,421
| +5% | +$134K |
|
|
BCYC
31
Bicycle Therapeutics
BCYC
$492M
| $2.86M | 1.04% |
158,293
+65,859
| +71% | +$1.19M |
|
32
Immunocore
IMCR
$1.78B
| $2.84M | 1.03% |
41,627
+1,823
| +5% | +$125K |
|
33
Legend Biotech
LEGN
$6.64B
| $2.67M | 0.97% |
44,305
| – | – |
|
34
Mastercard
MA
$536B
| $2.58M | 0.94% |
6,047
+2,300
| +61% | +$981K |
|
35
Indivior
INDV
$3.08B
| $2.49M | 0.9% |
164,841
+34,841
| +27% | +$526K |
|
36
Meta Platforms (Facebook)
META
$1.85T
| $2.44M | 0.89% |
6,890
+2,700
| +64% | +$956K |
|
37
Xenon Pharmaceuticals
XENE
$2.99B
| $2.39M | 0.87% |
51,801
+16,546
| +47% | +$762K |
|
38
Booking.com
BKNG
$181B
| $2.33M | 0.85% |
657
+300
| +84% | +$1.06M |
|
39
XPO
XPO
$14.8B
| $2.28M | 0.83% |
25,980
-200
| -0.8% | -$17.5K |
|
40
Xoma
XOMA
$421M
| $2.2M | 0.8% |
118,899
| – | – |
|
41
Dynavax Technologies
DVAX
$1.19B
| $2.18M | 0.79% |
156,161
+23,161
| +17% | +$324K |
|
42
GE Aerospace
GE
$293B
| $2.17M | 0.79% |
17,021
+7,100
| +72% | +$906K |
|
43
WESCO International
WCC
$10.6B
| $2.1M | 0.76% |
12,097
+5,200
| +75% | +$904K |
|
44
Fiserv
FI
$74.3B
| $1.99M | 0.72% |
14,953
+4,000
| +37% | +$531K |
|
45
Intuit
INTU
$187B
| $1.98M | 0.72% |
3,163
+1,000
| +46% | +$625K |
|
46
Travere Therapeutics
TVTX
$1.75B
| $1.97M | 0.72% |
219,416
+97,016
| +79% | +$872K |
|
47
Laureate Education
LAUR
$4.12B
| $1.95M | 0.71% |
142,507
+74,600
| +110% | +$1.02M |
|
48
Enliven Therapeutics
ELVN
$1.24B
| $1.9M | 0.69% |
137,241
+12,654
| +10% | +$175K |
|
49
Immuneering
IMRX
$229M
| $1.87M | 0.68% |
254,513
| – | – |
|
50
Alphabet (Google) Class C
GOOG
$2.79T
| $1.85M | 0.67% |
13,136
-3,500
| -21% | -$493K |
|